Bioptik Technology Incorporation Past Earnings Performance
Past criteria checks 5/6
Bioptik Technology Incorporation has been growing earnings at an average annual rate of 45.7%, while the Medical Equipment industry saw earnings growing at 11.4% annually. Revenues have been growing at an average rate of 11% per year. Bioptik Technology Incorporation's return on equity is 10.3%, and it has net margins of 10.3%.
Key information
45.7%
Earnings growth rate
45.9%
EPS growth rate
| Medical Equipment Industry Growth | 11.5% |
| Revenue growth rate | 11.0% |
| Return on equity | 10.3% |
| Net Margin | 10.3% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How Bioptik Technology Incorporation makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 829 | 86 | 78 | 71 |
| 30 Sep 23 | 825 | 68 | 84 | 69 |
| 30 Jun 23 | 816 | 65 | 84 | 64 |
| 31 Mar 23 | 776 | 54 | 81 | 59 |
| 31 Dec 22 | 768 | 48 | 80 | 58 |
| 30 Sep 22 | 727 | 37 | 78 | 54 |
| 30 Jun 22 | 699 | 19 | 77 | 55 |
| 31 Mar 22 | 716 | 23 | 78 | 52 |
| 31 Dec 21 | 738 | 23 | 79 | 49 |
| 30 Sep 21 | 678 | 1 | 75 | 45 |
| 30 Jun 21 | 582 | -34 | 75 | 44 |
| 31 Mar 21 | 525 | -44 | 75 | 45 |
| 31 Dec 20 | 486 | -60 | 75 | 50 |
| 30 Sep 20 | 513 | -51 | 77 | 61 |
| 30 Jun 20 | 554 | -20 | 78 | 65 |
| 31 Mar 20 | 590 | -9 | 82 | 68 |
| 31 Dec 19 | 566 | 5 | 81 | 69 |
| 30 Sep 19 | 555 | 9 | 79 | 70 |
| 30 Jun 19 | 532 | -17 | 72 | 66 |
| 31 Mar 19 | 500 | 25 | 72 | 61 |
| 31 Dec 18 | 520 | 26 | 67 | 58 |
| 30 Sep 18 | 483 | 23 | 65 | 50 |
| 30 Jun 18 | 453 | 39 | 65 | 48 |
| 31 Mar 18 | 475 | -4 | 58 | 50 |
| 31 Dec 17 | 476 | -34 | 60 | 50 |
| 30 Sep 17 | 489 | -20 | 63 | 52 |
| 30 Jun 17 | 521 | -19 | 61 | 61 |
| 31 Mar 17 | 500 | -13 | 59 | 60 |
| 31 Dec 16 | 477 | 8 | 61 | 62 |
| 30 Sep 16 | 463 | 11 | 61 | 60 |
| 30 Jun 16 | 441 | 14 | 63 | 52 |
| 31 Mar 16 | 443 | 10 | 62 | 53 |
| 31 Dec 15 | 453 | 28 | 60 | 47 |
| 30 Sep 15 | 463 | 29 | 55 | 48 |
| 30 Jun 15 | 470 | 28 | 50 | 43 |
| 31 Mar 15 | 433 | 24 | 48 | 40 |
| 31 Dec 14 | 415 | 30 | 48 | 41 |
| 30 Sep 14 | 403 | 57 | 47 | 39 |
| 30 Jun 14 | 421 | 75 | 49 | 38 |
| 31 Mar 14 | 453 | 93 | 50 | 36 |
| 31 Dec 13 | 452 | 79 | 48 | 32 |
| 30 Sep 13 | 427 | 58 | 50 | 30 |
| 30 Jun 13 | 381 | 49 | 50 | 28 |
Quality Earnings: 4161 has high quality earnings.
Growing Profit Margin: 4161's current net profit margins (10.3%) are higher than last year (6.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 4161's earnings have grown significantly by 45.7% per year over the past 5 years.
Accelerating Growth: 4161's earnings growth over the past year (76.7%) exceeds its 5-year average (45.7% per year).
Earnings vs Industry: 4161 earnings growth over the past year (76.7%) exceeded the Medical Equipment industry -17.2%.
Return on Equity
High ROE: 4161's Return on Equity (10.3%) is considered low.